for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Merck to buy cancer drug developer VelosBio for $2.75 bln

Nov 5 (Reuters) - Merck & Co Inc said on Thursday it had agreed to acquire privately held VelosBio for $2.75 billion in cash to expand its cancer pipeline. (Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up